{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:20Z","timestamp":1791859040396,"version":"4.3.4"},"reference-count":101,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.pupt.2012.06.002","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T18:05:40Z","timestamp":1339783540000},"page":"430-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Emerging roles for cholesterol and lipoproteins in lung disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Kymberly M.","family":"Gowdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Fessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2012.06.002_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/01.CIR.0000082641.20034.6A","article-title":"Inflammation, metabolic syndrome, and diet responsiveness","volume":"108","author":"Grundy","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2012.06.002_bib2","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2009.1672","article-title":"Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006","volume":"302","author":"Kuklina","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.pupt.2012.06.002_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/thx.2005.057976","article-title":"Potential therapeutic role for statins in respiratory disease","volume":"61","author":"Hothersall","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2012.06.002_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pupt.2012.06.002_bib5","first-page":"233","volume":"407","author":"Lusis","year":"2000","journal-title":"Atherosclerosis Nat"},{"key":"10.1016\/j.pupt.2012.06.002_bib6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.107.720300","article-title":"Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention","volume":"117","author":"Grundy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2012.06.002_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00041433-200502000-00005","article-title":"ATP-binding cassette transporter AI and its role in HDL formation","volume":"16","author":"Lee","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pupt.2012.06.002_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1194\/jlr.M700200-JLR200","article-title":"SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL","volume":"49","author":"Yvan-Charvet","year":"2008","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/ATVBAHA.109.195693","article-title":"Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in\u00a0vivo","volume":"30","author":"Yasuda","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pupt.2012.06.002_bib11","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.4049\/jimmunol.180.5.3560","article-title":"Loss of ABCG1 results in chronic pulmonary inflammation","volume":"180","author":"Baldan","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib12","doi-asserted-by":"crossref","first-page":"21763","DOI":"10.1074\/jbc.M501759200","article-title":"Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis","volume":"280","author":"Li","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pupt.2012.06.002_bib13","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.108.793869","article-title":"Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions","volume":"118","author":"Yvan-Charvet","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2012.06.002_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pupt.2012.06.002_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2012.06.002_bib18","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/eji.201041316","article-title":"Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis","volume":"41","author":"Freigang","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib19","first-page":"1266","article-title":"Uptake of low density lipoproteins by the hamster lung. Interactions with capillary endothelium","volume":"134","author":"Nistor","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2012.06.002_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02534063","article-title":"Regulation of lung surfactant cholesterol metabolism by serum lipopoteins","volume":"15","author":"Hass","year":"1980","journal-title":"Lipids"},{"key":"10.1016\/j.pupt.2012.06.002_bib21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0891-5849(99)00139-2","article-title":"HDL is the major source of vitamin E for type II pneumocytes","volume":"27","author":"Kolleck","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib22","first-page":"L634","article-title":"Lipoprotein-stimulated surfactant secretion in alveolar type II cells: mediation by heterotrimeric G proteins","volume":"273","author":"Pian","year":"1997","journal-title":"Am J Phys"},{"key":"10.1016\/j.pupt.2012.06.002_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.14.2.288","article-title":"Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in\u00a0vitro","volume":"14","author":"Bjorkerud","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.pupt.2012.06.002_bib24","doi-asserted-by":"crossref","first-page":"L117","DOI":"10.1152\/ajplung.00218.2009","article-title":"Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury","volume":"298","author":"Vockeroth","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2012.06.002_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ppul.20772","article-title":"The effect of elevated dietary cholesterol on pulmonary surfactant function in adolescent mice","volume":"43","author":"McCrae","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pupt.2012.06.002_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0026-0495(80)90075-X","article-title":"Altered surfactant synthesis and function in rats with diet-induced hyperlipidemia","volume":"29","author":"Baritussio","year":"1980","journal-title":"Metabolism"},{"key":"10.1016\/j.pupt.2012.06.002_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1172\/JCI29968","article-title":"Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI\/II","volume":"117","author":"Dahl","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pupt.2012.06.002_bib28","doi-asserted-by":"crossref","first-page":"26331","DOI":"10.1074\/jbc.M403581200","article-title":"Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant","volume":"279","author":"Pulfer","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pupt.2012.06.002_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-2275(20)42253-9","article-title":"Uptake, metabolism, and cytotoxicity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells","volume":"32","author":"Sevanian","year":"1991","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1010914306375","article-title":"Comparative study of the cytotoxicity and apoptosis-inducing potential of commonly occurring oxysterols","volume":"17","author":"O'Callaghan","year":"2001","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.pupt.2012.06.002_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","article-title":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury","volume":"133","author":"Imai","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.pupt.2012.06.002_bib32","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1194\/jlr.M004549","article-title":"Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung","volume":"51","author":"Wang","year":"2010","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib33","doi-asserted-by":"crossref","first-page":"L991","DOI":"10.1152\/ajplung.00013.2008","article-title":"Apoetm1Unc mice have impaired alveologenesis, low lung function, and rapid loss of lung function","volume":"294","author":"Massaro","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2012.06.002_bib34","doi-asserted-by":"crossref","first-page":"L980","DOI":"10.1152\/ajplung.00234.2005","article-title":"Pulmonary abnormalities due to ABCA1 deficiency in mice","volume":"289","author":"Bates","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2012.06.002_bib35","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.180.6.4273","article-title":"A\u00a0critical role for ABCG1 in macrophage inflammation and lung homeostasis","volume":"180","author":"Wojcik","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib36","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1194\/jlr.P700022-JLR200","article-title":"ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis","volume":"48","author":"Thomassen","year":"2007","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1164\/rccm.200910-1580OC","article-title":"ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung","volume":"182","author":"Draper","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib38","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1101605","article-title":"ATP binding cassette transporter G1 deletion induces IL-17-dependent dysregulation of pulmonary adaptive immunity","author":"Draper","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib39","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1164\/rccm.201002-0308OC","article-title":"Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptor-mediated pathway","volume":"182","author":"Yao","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib40","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M109.047753","article-title":"Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury","volume":"284","author":"Gong","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pupt.2012.06.002_bib41","doi-asserted-by":"crossref","first-page":"31882","DOI":"10.1074\/jbc.M703278200","article-title":"Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses","volume":"282","author":"Birrell","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pupt.2012.06.002_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1465-9921-11-19","article-title":"Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation","volume":"11","author":"Crisafulli","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib43","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.4049\/jimmunol.180.5.3305","article-title":"Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense","volume":"180","author":"Smoak","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib44","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1172\/JCI35288","article-title":"Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice","volume":"119","author":"Korf","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pupt.2012.06.002_bib45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0022-2275(20)33383-6","article-title":"Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin","volume":"40","author":"Babiker","year":"1999","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib46","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4049\/jimmunol.0903501","article-title":"Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes","volume":"185","author":"Madenspacher","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib47","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1128\/IAI.00037-08","article-title":"Hypercholesterolemia impairs immunity to tuberculosis","volume":"76","author":"Martens","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.pupt.2012.06.002_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000053834","article-title":"Dietary cholesterol enhances pulmonary eosinophilic inflammation in a murine model of asthma","volume":"125","author":"Yeh","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jaci.2009.08.005","article-title":"Novel relationship of serum cholesterol with asthma and wheeze in the United States","volume":"124","author":"Fessler","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib50","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.4049\/jimmunol.172.5.2903","article-title":"A\u00a0novel anti-inflammatory role of simvastatin in a murine model of allergic asthma","volume":"172","author":"McKay","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF02256124","article-title":"Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammation","volume":"11","author":"Yeh","year":"2004","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.pupt.2012.06.002_bib52","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.200501-041OC","article-title":"Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs","volume":"172","author":"Lee","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1164\/rccm.200406-729OC","article-title":"A\u00a0role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense","volume":"171","author":"Fessler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-011-0807-4","article-title":"Simvastatin has beneficial effect on pulmonary artery hypertension by inhibiting NF-kappaB expression","volume":"354","author":"Liu","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pupt.2012.06.002_bib55","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1440-1681.2010.05431.x","article-title":"Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis","volume":"37","author":"Kim","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pupt.2012.06.002_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/pds.1715","article-title":"Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study","volume":"18","author":"Myles","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.pupt.2012.06.002_bib57","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thx.2006.062885","article-title":"Statin treatment and reduced risk of pneumonia in patients with diabetes","volume":"61","author":"van de Garde","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2012.06.002_bib58","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjmed.2008.06.030","article-title":"Prior statin use is associated with improved outcomes in community-acquired pneumonia","volume":"121","author":"Chalmers","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib59","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1183\/09031936.00162006","article-title":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia","volume":"31","author":"Mortensen","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2012.06.002_bib60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1465-9921-6-82","article-title":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia","volume":"6","author":"Mortensen","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1592\/phco.27.3.325","article-title":"Statins and the risk of pneumonia: a population-based, nested case-control study","volume":"27","author":"Schlienger","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pupt.2012.06.002_bib62","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.168.19.2081","article-title":"Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients","volume":"168","author":"Thomsen","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib63","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.38992.565972.7C","article-title":"Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study","volume":"333","author":"Majumdar","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.pupt.2012.06.002_bib64","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/thx.2010.138990","article-title":"Simvastatin in the treatment of asthma: lack of steroid-sparing effect","volume":"65","author":"Cowan","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2012.06.002_bib65","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jaci.2010.08.005","article-title":"Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase","volume":"126","author":"Maneechotesuwan","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib66","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/thx.2008.100198","article-title":"Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma","volume":"63","author":"Hothersall","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2012.06.002_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187231211794455217","article-title":"Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research","volume":"5","author":"Zeki","year":"2011","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.pupt.2012.06.002_bib68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.00106406","article-title":"Statin use is associated with reduced mortality in COPD","volume":"29","author":"Soyseth","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2012.06.002_bib69","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1742-1241.2008.01731.x","article-title":"Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study","volume":"62","author":"Blamoun","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.pupt.2012.06.002_bib70","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1378\/chest.127.4.1446","article-title":"Simvastatin treatment of pulmonary hypertension: an observational case series","volume":"127","author":"Kao","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2012.06.002_bib71","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/rccm.200205-410OC","article-title":"Statin use is associated with improved function and survival of lung allografts","volume":"167","author":"Johnson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib72","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00134-009-1421-8","article-title":"Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury","volume":"35","author":"Kor","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib73","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.201003-0423OC","article-title":"A\u00a0randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP study)","volume":"183","author":"Craig","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib74","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2011.1649","article-title":"Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial","volume":"306","author":"Nicholls","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.pupt.2012.06.002_bib75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/clpt.2011.271","article-title":"Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction","volume":"91","author":"Gutstein","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pupt.2012.06.002_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2466-11-16","article-title":"Effects of short-term treatment with atorvastatin in smokers with asthma\u2013a randomized controlled trial","volume":"11","author":"Braganza","year":"2011","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib77","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib78","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1210\/me.2007-0017","article-title":"Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells","volume":"21","author":"Delvecchio","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pupt.2012.06.002_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/JIR.S12983","article-title":"Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis","volume":"4","author":"Getz","year":"2011","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib80","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4049\/jimmunol.1001534","article-title":"5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma","volume":"186","author":"Yao","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib81","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1194\/jlr.M012724","article-title":"D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma","volume":"52","author":"Nandedkar","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib82","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/01.CIR.0000030182.35880.3E","article-title":"Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide","volume":"106","author":"Van Lenten","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2012.06.002_bib83","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.200901-0018OC","article-title":"Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond","volume":"180","author":"Zeki","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib84","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1465-9921-12-113","article-title":"Simvastatin inhibits TGFbeta1-induced fibronectin in human airway fibroblasts","volume":"12","author":"Schaafsma","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2012.06.002_bib85","doi-asserted-by":"crossref","first-page":"L1026","DOI":"10.1152\/ajplung.00354.2004","article-title":"Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury","volume":"288","author":"Jacobson","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2012.06.002_bib86","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1161\/01.CIR.0000147232.75456.B3","article-title":"D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes","volume":"110","author":"Van Lenten","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2012.06.002_bib87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cyto.2008.04.002","article-title":"Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid","volume":"43","author":"Jiao","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.pupt.2012.06.002_bib88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.lfs.2006.02.011","article-title":"Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice","volume":"79","author":"Yan","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.pupt.2012.06.002_bib89","doi-asserted-by":"crossref","first-page":"L882","DOI":"10.1152\/ajplung.00238.2007","article-title":"Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice","volume":"294","author":"Takahashi","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2012.06.002_bib90","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1165\/rcmb.2004-0127OC","article-title":"Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts","volume":"32","author":"Watts","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2012.06.002_bib91","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.200905-0659OC","article-title":"Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis","volume":"182","author":"Kim","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib92","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1164\/rccm.200705-656OC","article-title":"Statin use reduces decline in lung function: VA normative aging study","volume":"176","author":"Alexeeff","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib93","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1378\/chest.07-0298","article-title":"The use of statins and lung function in current and former smokers","volume":"132","author":"Keddissi","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2012.06.002_bib94","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1378\/chest.06-1997","article-title":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins","volume":"131","author":"Frost","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2012.06.002_bib95","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1620\/tjem.212.265","article-title":"Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan","volume":"212","author":"Ishida","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.pupt.2012.06.002_bib96","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2006.04.039","article-title":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease","volume":"47","author":"Mancini","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pupt.2012.06.002_bib97","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2362.2010.02434.x","article-title":"Statin use in patients with asthma: a nationwide population-based study","volume":"41","author":"Huang","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pupt.2012.06.002_bib98","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaci.2006.10.014","article-title":"Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma","volume":"119","author":"Menzies","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib99","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1081-1206(10)60261-X","article-title":"The effect of statin therapy on allergic patients with asthma","volume":"103","author":"Ostroukhova","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2012.06.002_bib100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.126.2.438","article-title":"Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis","volume":"126","author":"Nadrous","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2012.06.002_bib101","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/CS20080241","article-title":"Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"116","author":"Lee","year":"2009","journal-title":"Clin Sci (Lond)"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553912000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553912000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T05:12:13Z","timestamp":1642482733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553912000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1094553912000776"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2012.06.002","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging roles for cholesterol and lipoproteins in lung disease","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2012.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}